Will Kangmei Pharmaceutical's investor claim be the first class action case in China? There are disputes in these places | China Business Blog

Aggregated China Business Blogs

2021-01-03

Will Kangmei Pharmaceutical's investor claim be the first class action case in China? There are disputes in these places

Aggregated Source: Caishen.Co

Caishen.Co delivers Primary Data for China`s Secondary Investment and Stock Markets. Full details at Caishen.Co.

Original URL: Click here to visit original article
Copyright Caishen.Co